Renaissance Technologies - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 63 filers reported holding AMRYT PHARMA PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$1,439
+311.1%
98,700
+105.6%
0.00%
Q4 2022$350
-99.9%
48,000
+0.6%
0.00%
Q3 2022$330,000
+0.6%
47,700
+1.7%
0.00%
Q2 2022$328,000
+54.0%
46,900
+81.8%
0.00%
Q1 2022$213,000
+10.4%
25,800
+44.1%
0.00%
Q4 2021$193,000
-28.5%
17,900
-19.7%
0.00%
Q2 2021$270,00022,3000.00%
Other shareholders
AMRYT PHARMA PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders